{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Enasidenib mesylateCAS：1650550-25-6
Molecular Formula：C20H21F6N7O4S
Molecular Weight：569.48
Storage：Powder:2-8℃，2 years;Insolvent(mother liquid):-20℃，6 months;-80℃，1 year
Purity：≥98%
Appearance：White to off-white Solid
Qty：
Size：
| CAS | 1650550-25-6 |
| Name | Enasidenib mesylate |
| Molecular Formula | C20H21F6N7O4S |
| Molecular Weight | 569.48 |
| Solubility | Soluble in DMSO ≥10mg/mL |
| Purity | ≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(mother liquid):-20℃，6 months;-80℃，1 year |
| Target Point | Isocitrate Dehydrogenase (IDH) |
| Passage | Metabolic Enzyme&Protease |
| Background | Enasidenib mesylate (AG-221 mesylate) is a potent and selective IDH2 mutant enzyme inhibitor that promotes the differentiation of leukemia myeloblasts and can be used in the treatment of acute myeloid leukemia. |
| Unit | Bottle |
| Specification | 5mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
